193 related articles for article (PubMed ID: 9176436)
21. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
22. Fertility drugs and cancer: a guideline.
;
Fertil Steril; 2016 Dec; 106(7):1617-1626. PubMed ID: 27573989
[TBL] [Abstract][Full Text] [Related]
23. Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gronwald J; Glass K; Rosen B; Karlan B; Tung N; Neuhausen SL; Moller P; Ainsworth P; Sun P; Narod SA; Lubinski J; Kotsopoulos J;
Fertil Steril; 2016 Mar; 105(3):781-785. PubMed ID: 26698676
[TBL] [Abstract][Full Text] [Related]
24. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
[TBL] [Abstract][Full Text] [Related]
25. In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk.
Stewart LM; Holman CD; Aboagye-Sarfo P; Finn JC; Preen DB; Hart R
Gynecol Oncol; 2013 Feb; 128(2):260-4. PubMed ID: 23116937
[TBL] [Abstract][Full Text] [Related]
26. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis.
Kashyap S; Moher D; Fung MF; Rosenwaks Z
Obstet Gynecol; 2004 Apr; 103(4):785-94. PubMed ID: 15051576
[TBL] [Abstract][Full Text] [Related]
27. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
28. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women.
Jensen A; Sharif H; Olsen JH; Kjaer SK
Am J Epidemiol; 2008 Jul; 168(1):49-57. PubMed ID: 18448441
[TBL] [Abstract][Full Text] [Related]
29. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study.
Potashnik G; Lerner-Geva L; Genkin L; Chetrit A; Lunenfeld E; Porath A
Fertil Steril; 1999 May; 71(5):853-9. PubMed ID: 10231045
[TBL] [Abstract][Full Text] [Related]
30. Assisted reproductive technology and ovarian cancer.
Devesa M; Barri PN; Coroleu B
Minerva Endocrinol; 2010 Dec; 35(4):247-57. PubMed ID: 21178919
[TBL] [Abstract][Full Text] [Related]
31. Use of fertility drugs and risk of ovarian cancer.
Diergaarde B; Kurta ML
Curr Opin Obstet Gynecol; 2014 Jun; 26(3):125-9. PubMed ID: 24752005
[TBL] [Abstract][Full Text] [Related]
32. Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.
Reigstad MM; Storeng R; Myklebust TÅ; Oldereid NB; Omland AK; Robsahm TE; Brinton LA; Vangen S; Furu K; Larsen IK
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):953-962. PubMed ID: 28108444
[No Abstract] [Full Text] [Related]
33. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
34. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study.
Baldur-Felskov B; Kjaer SK; Albieri V; Steding-Jessen M; Kjaer T; Johansen C; Dalton SO; Jensen A
Hum Reprod; 2013 Mar; 28(3):683-90. PubMed ID: 23223399
[TBL] [Abstract][Full Text] [Related]
35. Treatment for fertility and risk of ovarian tumors of borderline malignancy.
Parazzini F; Negri E; La Vecchia C; Moroni S; Polatti A; Chiaffarino F; Surace M; Ricci E
Gynecol Oncol; 1998 Mar; 68(3):226-8. PubMed ID: 9570970
[TBL] [Abstract][Full Text] [Related]
36. The feasibility of assessing women's perceptions of the risks and benefits of fertility drug therapy in relation to ovarian cancer risk.
Rosen B; Irvine J; Ritvo P; Shapiro H; Stewart D; Reynolds K; Robinson G; Thomas J; Neuman J; Murphy J
Fertil Steril; 1997 Jul; 68(1):90-4. PubMed ID: 9207590
[TBL] [Abstract][Full Text] [Related]
37. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
39. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.
Kotsopoulos J; Librach CL; Lubinski J; Gronwald J; Kim-Sing C; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Randall S; Manoukian S; Pasini B; Tung N; Ainsworth PJ; Cummings S; Sun P; Narod SA;
Cancer Causes Control; 2008 Dec; 19(10):1111-9. PubMed ID: 18509731
[TBL] [Abstract][Full Text] [Related]
40. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.
Kurta ML; Moysich KB; Weissfeld JL; Youk AO; Bunker CH; Edwards RP; Modugno F; Ness RB; Diergaarde B
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1282-92. PubMed ID: 22707710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
